Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development

Thromb Haemost. 1995 Jul;74(1):396-400.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aspirin / administration & dosage
  • Aspirin / therapeutic use
  • Clinical Trials as Topic
  • Clinical Trials, Phase II as Topic
  • Cyclooxygenase Inhibitors / pharmacology
  • Drug Design*
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Nephelometry and Turbidimetry
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / chemistry
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Thromboxane A2 / biosynthesis
  • Thromboxane B2 / urine
  • Thromboxane-A Synthase / antagonists & inhibitors

Substances

  • Cyclooxygenase Inhibitors
  • Enzyme Inhibitors
  • Platelet Aggregation Inhibitors
  • Thromboxane B2
  • Thromboxane A2
  • Thromboxane-A Synthase
  • Aspirin